Bethesda Hospital in St. Paul, Minnesota, is starting to use dexamethasone as standard caer for treating COVID-19 patients.
ICU Medical Director Dr. Erica Kuhlmann, who is also chief of staff at Bethesda, told KTSP that dexamethasoneis widely available and inexpensive:
The result of giving steroids is more impressive than the convalescent plasma, in my personal experience, and in the data we have so far. It’s not something that we have to go back and manufacture a whole new stockpile of. We have it already in circulation and we’ve been using it for a long time for other illnesses.
Researchers at the University of Oxford in England were the first to perform a clinical trial with dexamethasone and COVID-19 patients.
The New York Times reported on the breakthrough achieved by socialist healthcare in the UK in June:
The drug appears to reduce inflammation caused by the immune system, protecting the tissues. In the study, dexamethasone reduced deaths of patients on ventilators by one-third, and deaths of patients on oxygen by one-fifth.